Epidemiology
- Indications
- Parasitic Infections
- Transitional Cell Cancer
- Psoriasis
Pharmacology
- Dihydrofolate Reductase Inhibitor (closely related to methotrexate)
Adeverse Effects
- Interstitial Pneumonitis (see Interstitial Lung Disease-Etiology)
- Epidemiology: occurs in 14% of cases
- Treatment: withdrawal of drug
References
- Piritrexim-induced pulmonary toxicity. Am J Clin Oncol. 1993 Apr;16(2):146-8